|
US7731972B1
(en)
*
|
2000-02-04 |
2010-06-08 |
Vlaams Interuniversitair Instituut Voor Biotechnologie |
Immunoprotective influenza antigen and its use in vaccination
|
|
WO1999022763A2
(en)
*
|
1997-10-31 |
1999-05-14 |
Cistron Biotechnology, Inc. |
Encapsulated immunomodulators useful as vaccine adjuvants
|
|
AT407958B
(de)
|
1999-02-11 |
2001-07-25 |
Immuno Ag |
Inaktivierte influenza-virus-vakzine zur nasalen oder oralen applikation
|
|
DE60117164T2
(de)
*
|
2000-11-07 |
2006-08-03 |
Immuno Vaccine Technologies Inc., Halifax |
Impfstoffe mit erhöhter immunantwort und verfahren zur deren herstellung
|
|
AU2002236526B9
(en)
*
|
2000-11-15 |
2008-05-01 |
The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Sol-fusin: use of GP64-6His to catalyze membrane fusion
|
|
MY134424A
(en)
*
|
2001-05-30 |
2007-12-31 |
Saechsisches Serumwerk |
Stable influenza virus preparations with low or no amount of thiomersal
|
|
JP2005525992A
(ja)
*
|
2001-06-25 |
2005-09-02 |
イサム・リサーチ・デベロツプメント・カンパニー・オブ・ザ・ヘブルー・ユニバーシテイ・オブ・エルサレム |
生物学的物質を充填した小胞の調製法およびそれらの様々な使用
|
|
CA2452008C
(en)
*
|
2001-07-05 |
2012-03-06 |
Virocell Inc. |
Ltb4 as vaccine adjuvant
|
|
WO2004004687A2
(en)
*
|
2002-07-03 |
2004-01-15 |
Aphton Corporation |
Liposomal vaccine
|
|
US20050169979A1
(en)
*
|
2002-07-03 |
2005-08-04 |
Dov Michaeli |
Liposomal vaccine
|
|
US20040247661A1
(en)
*
|
2002-07-03 |
2004-12-09 |
Dov Michaeli |
Liposomal vaccine
|
|
AU2004233873B2
(en)
|
2003-04-25 |
2010-11-18 |
The Penn State Research Foundation |
Method and system for systemic delivery of growth arresting, lipid-derived bioactive compounds
|
|
AU2004238076A1
(en)
*
|
2003-05-09 |
2004-11-25 |
Novosom Ag |
Injectable liposomal depots for delivering active ingredients
|
|
CN1867355A
(zh)
*
|
2003-08-11 |
2006-11-22 |
财团法人阪大微生物病研究会 |
包含诱导粘膜免疫的佐剂的新型疫苗
|
|
WO2005018610A1
(en)
*
|
2003-08-21 |
2005-03-03 |
Lipotek Pty Ltd |
In vivo targeting of dendritic cells
|
|
FR2868951B1
(fr)
*
|
2004-04-15 |
2006-07-21 |
Ethypharm Sa |
Compositions contenant ds vesicules lamellaires incorporant un principe actif peu soluble dans l'eau et produits intermediaires utiles pour leur preparation
|
|
US20050260260A1
(en)
*
|
2004-05-19 |
2005-11-24 |
Edward Kisak |
Liposome compositions for the delivery of macromolecules
|
|
US20060177468A1
(en)
*
|
2005-01-05 |
2006-08-10 |
Philadelphia Health and Education Corporation (d/b/a Drexel University College of Medicine |
Delivery vehicles, bioactive substances and viral vaccines
|
|
CA2523032A1
(en)
|
2005-10-07 |
2007-04-07 |
Immunovaccine Technologies Inc. |
Vaccines for cancer therapy
|
|
CN106310293A
(zh)
|
2007-09-27 |
2017-01-11 |
免疫疫苗技术有限公司 |
在包括连续疏水相的载体中的脂质体在体内输送多核苷酸中的应用
|
|
US20100209452A1
(en)
*
|
2007-10-03 |
2010-08-19 |
Immunovaccine Technologies, Inc |
Compositions comprising an antigen, an amphipathic compound and a hydrophobic carrier, and uses thereof
|
|
EP2231180B1
(en)
*
|
2008-01-16 |
2016-08-17 |
Ben-gurion University Of The Negev Research And Development Authority |
Vaccine for alzheimer's disease
|
|
WO2009146523A1
(en)
*
|
2008-06-05 |
2009-12-10 |
Immunovaccine Technologies Inc. |
Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substance
|
|
EP2299953B1
(en)
*
|
2008-07-14 |
2017-04-12 |
Polypid Ltd. |
Sustained-release drug carrier composition
|
|
US20120157419A1
(en)
|
2009-02-02 |
2012-06-21 |
Tuvia Gilat |
Methods and compositions for treating alzheimer's disease
|
|
CA2803282C
(en)
|
2009-07-06 |
2018-05-01 |
David E. Anderson |
Methods for preparing vesicles and formulations produced therefrom
|
|
JP5854559B2
(ja)
|
2009-07-06 |
2016-02-09 |
ヴァリエーション バイオテクノロジーズ インコーポレイテッド |
小胞を調製する方法及びこれから製造される製剤
|
|
IN2012DN00570A
(enExample)
|
2009-07-14 |
2015-06-12 |
Polypid Ltd |
|
|
US9592287B2
(en)
|
2009-10-09 |
2017-03-14 |
New York Blood Center, Inc. |
Immunopotentiator-linked oligomeric influenza immunogenic compositions
|
|
EP2525778B1
(en)
|
2010-01-19 |
2018-08-01 |
Polypid Ltd. |
Sustained-release nucleic acid matrix compositions
|
|
WO2012006367A2
(en)
*
|
2010-07-06 |
2012-01-12 |
Variation Biotechnologies, Inc. |
Compositions and methods for treating influenza
|
|
US10736844B2
(en)
|
2011-01-13 |
2020-08-11 |
Variation Biotechnologies Inc. |
Compositions and methods for treating viral infections
|
|
BR112013018074A2
(pt)
|
2011-01-13 |
2020-12-01 |
Variation Biotechnologies, Inc. |
métodos para a preparação de vesículas e formulações produzidas a partir dessas
|
|
CN113876945A
(zh)
|
2011-10-06 |
2022-01-04 |
免疫疫苗技术有限公司 |
包括激活或增加tlr2活性的佐剂的脂质体组合物及其应用
|
|
US20140328876A1
(en)
|
2011-11-18 |
2014-11-06 |
Variation Biotechnologies Inc. |
Synthetic derivatives of mpl and uses thereof
|
|
AU2013208693B2
(en)
|
2012-01-12 |
2017-12-07 |
Variation Biotechnologies Inc. |
Compositions and methods for treating viral infections
|
|
EP2806894A4
(en)
|
2012-01-27 |
2015-11-04 |
Variation Biotechnologies Inc |
METHODS AND COMPOSITIONS FOR THERAPEUTIC AGENTS
|
|
CN103736090B
(zh)
*
|
2014-01-27 |
2016-03-02 |
中国医学科学院医学生物学研究所 |
甲磺酸去铁胺佐剂及含甲磺酸去铁胺佐剂的疫苗
|
|
CN110151702A
(zh)
*
|
2019-06-24 |
2019-08-23 |
昆明医科大学 |
聚乙二醇修饰流感疫苗脂质体及其制备方法
|